USP 800 Exceptions for Antineoplastics

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

9 posts / 0 new
Log in or register to post comments
Last post
Mon, 03/11/2024 - 16:29
#1
Tim Coffey
Tim Coffey's picture
Offline
Last seen: 3 weeks 6 days ago
Joined: 08/31/2022 - 12:08
USP 800 Exceptions for Antineoplastics

Does anyone have any USP 800 practice exceptions surrounding the use of methotrexate in ectopic pregnancy that allows its use for this indication outside of a sterile compounding containment environment? e.g., assessment of risk (AoR) that delineates appropriate storage, handling, disposal that would allow the frontline nursing staff to draw up and administer these onetime intramuscular doses.

Thank you!

Top